Marion Malphettes Selected Research

Brentuximab Vedotin

7/2014

Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marion Malphettes Research Topics

Disease

4	Infections 11/2022 - 05/2008
3	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 10/2011
3	Aspergillosis 12/2019 - 12/2017
3	Mycoses (Diseases, Fungus) 12/2019 - 12/2017
3	Lymphoma (Lymphomas) 03/2015 - 04/2004
2	Fever (Fevers) 01/2022 - 08/2007
2	IgA Deficiency 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Agammaglobulinemia (Hypogammaglobulinemia) 07/2018 - 07/2010
2	Neutropenia 01/2018 - 01/2013
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 05/2008
2	Common Variable Immunodeficiency 11/2016 - 05/2008
2	Multiple Myeloma 02/2011 - 03/2003
1	Liver Diseases (Liver Disease) 11/2022
1	Hepatitis E 11/2022
1	Campylobacter Infections (Campylobacter Infection) 05/2022
1	Panniculitis 05/2022
1	Diarrhea 05/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2022
1	Arthritis (Polyarthritis) 05/2022
1	Multi-centric Castleman's Disease 01/2022
1	Anemia 01/2022
1	Edema (Dropsy) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Castleman Disease (Castleman's Disease) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019
1	Immunoglobulin Light-chain Amyloidosis 11/2019
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 11/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2019
1	Hemolytic Anemia 10/2019
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Cutis Laxa 10/2018
1	Invasive Fungal Infections 01/2018
1	Lymphoid Leukemia 01/2018
1	Meningoencephalitis 12/2017
1	Hypotension (Low Blood Pressure) 12/2017
1	Smoldering Multiple Myeloma 11/2017
1	Primary Effusion Lymphoma 01/2017
1	Demyelinating Diseases (Demyelinating Disease) 09/2016
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 09/2016
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2015
1	Skin Diseases (Skin Disease) 11/2015
1	Purpura 03/2015
1	Monoclonal Gammopathy of Undetermined Significance 03/2015
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 07/2014
1	Hodgkin Disease (Hodgkin's Disease) 11/2013
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2013
1	Second Primary Neoplasms (Neoplasms, Second) 01/2013
1	Xanthomatosis (Xanthoma) 10/2011
1	Glomerulonephritis 02/2011
1	Persistent Infection 05/2008
1	Reinfection 05/2008
1	Pneumonia (Pneumonitis) 05/2008

Drug/Important Bio-Agent (IBA)

6	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 05/2008
6	Immunoglobulin G (IgG)IBA 11/2022 - 05/2008
6	Immunoglobulin M (IgM)IBA 11/2022 - 08/2007
4	ibrutinibIBA 05/2022 - 12/2017
3	Biological ProductsIBA 01/2021 - 02/2011
3	Immunoglobulin A (IgA)IBA 01/2018 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2016
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2022
1	ParaproteinsIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	romidepsin (FK228)FDA Link 11/2019
1	Amyloid (Amyloid Fibrils)IBA 11/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019
1	Bortezomib (Velcade)FDA Link 10/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	1,2,3,4,6,7,8-heptachlorodibenzodioxinIBA 10/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Conjugate VaccinesIBA 11/2017
1	Talc FDA Link 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2015
1	ChemokinesIBA 11/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2015
1	CytokinesIBA 11/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 11/2015
1	Epidermal Growth Factor (EGF)IBA 11/2015
1	Brentuximab VedotinIBA 07/2014
1	Bendamustine Hydrochloride FDA Link 11/2013
1	purineIBA 01/2013
1	fludarabineIBA 01/2013
1	Chlorambucil (Leukeran)FDA Link 01/2013
1	Monoclonal AntibodiesIBA 01/2013
1	Alkylating AgentsIBA 01/2013
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2011
1	Lipoproteins (Lipoprotein)IBA 10/2011

Therapy/Procedure

9	Therapeutics 11/2022 - 03/2003
1	Off-Label Use 10/2019
1	Central Venous Catheters 10/2019
1	Pleurodesis 01/2017
1	Drug Therapy (Chemotherapy) 10/2011